Rocky Mountain Cancer Centers is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers has participated in 138 clinical trials with 36 currently active.
Therapeutic areas: Oligometastatic Prostate Cancer (OMPC), Pancreatic Adenocarcinoma, Carcinoma, Non-Small-Cell Lung.
Sponsors: Novartis Pharmaceuticals, ImmunoGenesis, Sanofi.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Colorado · View every site in Denver
Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers has 138 clinical trials on record, with 36 currently active. Their work covers Oligometastatic Prostate Cancer (OMPC), Pancreatic Adenocarcinoma, Carcinoma, Non-Small-Cell Lung.
Rocky Mountain Cancer Centers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.